Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

President Donald Trump announces an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their GLP-1 ...

The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in ...

Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.

A new US government deal with drugmakers Eli Lilly and Novo Nordisk will slash prices for popular weight-loss drugs like ...

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

US President Donald Trump has announced deals that aim to lower the cost of popular weight loss drugs, as phramaceutical prices take centre stage in his administration's messaging around affordability ...

The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices ...

President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their ...

The prices of Ozempic and Wegovy will fall from $1,000 and $1,350 per month, respectively, to $350 when purchased through ...

The Trump administration announced a deal with Eli Lilly and Novo Nordisk to lower the costs of GLP-1 medications, which may ...